D'arrigo, P.* , Dubois, M.* , Sanchez Gil, J., Lassence, C., Hego, A., Brouwers, B., Lombard, A., Rogister, B., Neirinckx, V., Lebrun, M.* , & Sadzot, C.*. (18 December 2025). An oncolytic herpesvirus expressing a CXCR4 antagonist interferes with glioblastoma cells' stemness features and migration. Molecular Therapy. Oncology, 33 (4), 201083. doi:10.1016/j.omton.2025.201083 * These authors have contributed equally to this work. |
Sanchez Gil, J., Dubois, M., Neirinckx, V., LOMBARD, A., Coppieters't Wallant, N., D'arrigo, P., Isci, D., Aldenhoff, T., Brouwers, B., Lassence, C., ROGISTER, B., Lebrun, M., & Sadzot, C. (2022). Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: a proof-of-principle. Molecular Therapy: Oncolytics. doi:10.1016/j.omto.2022.06.002 |